Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Rouse

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Diagnostic Microbiology and Infectious Disease|April 24, 2007
In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infectionMark S Rouse, James M Steckelberg, Robin Patel
Clinical Orthopaedics and Related Research|October 22, 2010
Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?Mark S Rouse, Andras Heijink, James M Steckelberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2004
Improved survival in experimental sepsis with an orally administered inhibitor of apoptosisJoel G R Weaver, Mark S Rouse, James M Steckelberg, et al.
Diagnostic Microbiology and Infectious Disease|April 25, 2006
Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumoniaMark S Rouse, Melanie M Hein, Paloma Anguita-Alonso, et al.
The Journal of Infectious Diseases|August 10, 2006
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection modelJennifer A Shuford, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Anidulafungin treatment of candidal central nervous system infection in a murine modelCheol-In Kang, Mark S Rouse, Jayawant N Mandrekar, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepimeSamer A Alyaseen, Kerryl E Piper, Mark S Rouse, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Garenoxacin treatment of experimental endocarditis caused by viridans group streptococciPaloma Anguita-Alonso, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2008
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical currentJose L del Pozo, Mark S Rouse, Jayawant N Mandrekar, et al.
International Journal of Microbiology|December 14, 2011
The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic SensitizationHongxia Zhao, Cheol-In Kang, Mark S Rouse, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Diagnostic Microbiology and Infectious Disease|April 24, 2007
In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infectionMark S Rouse, James M Steckelberg, Robin Patel
Clinical Orthopaedics and Related Research|October 22, 2010
Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?Mark S Rouse, Andras Heijink, James M Steckelberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2004
Improved survival in experimental sepsis with an orally administered inhibitor of apoptosisJoel G R Weaver, Mark S Rouse, James M Steckelberg, et al.
Diagnostic Microbiology and Infectious Disease|April 25, 2006
Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumoniaMark S Rouse, Melanie M Hein, Paloma Anguita-Alonso, et al.
The Journal of Infectious Diseases|August 10, 2006
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection modelJennifer A Shuford, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Anidulafungin treatment of candidal central nervous system infection in a murine modelCheol-In Kang, Mark S Rouse, Jayawant N Mandrekar, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepimeSamer A Alyaseen, Kerryl E Piper, Mark S Rouse, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Garenoxacin treatment of experimental endocarditis caused by viridans group streptococciPaloma Anguita-Alonso, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2008
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical currentJose L del Pozo, Mark S Rouse, Jayawant N Mandrekar, et al.
International Journal of Microbiology|December 14, 2011
The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic SensitizationHongxia Zhao, Cheol-In Kang, Mark S Rouse, et al.
Pageof 3